Sponsor of the Day:
Jerkmate
https://www.statnews.com/2026/02/05/nektar-therapeutics-eczema-atopic-dermatitis-rezpeg/
Nektar Therapeutics is trying to stage a comeback. But a big test awaits
Upcoming results from a mid-stage trial of rezepg, a treatment for eczema, or atopic dermatitis, could be pivotal for the drugmaker.
nektar therapeuticsbig testtryingstagecomeback
https://www.nektar.com/our-pipeline/
Our Pipeline | Nektar Therapeutics
Sep 2, 2025 - Nektar's pipeline features rezpegaldesleukin for atopic dermatitis, alopecia areata, and diabetes, plus other autoimmune programs and beyond.
nektar therapeuticspipeline
https://www.fool.com/investing/2025/10/05/heres-why-nektar-therapeutics-stock-rocketed-906-h/
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September | The Motley Fool
Oct 5, 2025 - Results of the Resolve-AD trial with rezpegaldesleukin were better than expected.
nektar therapeutics90 6motley foolstockrocketed